Anti-Mazdutide Polyclonal Antibody from ProteoGenix; catalogue ARO-A22578; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Mazdutide polyclonal antibody is designed for the detection and characterization of Mazdutide (IBI362, LY3305677) in research applications. Mazdutide is an investigational peptide therapeutic targeting metabolic pathways involved in glucose regulation and body weight control. Antibodies recognizing Mazdutide are valuable tools for studies focusing on peptide therapeutics, metabolic disorders, and drug development.
This Mazdutide antibody enables researchers to detect the molecule in experimental samples and to support analytical workflows related to therapeutic peptide research and assay development.
Mazdutide (also known as IBI362 or LY3305677) is a dual-agonist peptide targeting receptors involved in metabolic regulation. It is currently investigated for the treatment of obesity and metabolic diseases, and has attracted significant attention in pharmaceutical and academic research.
Because of the increasing interest in GLP-1 and metabolic pathway therapeutics, tools that enable reliable detection of Mazdutide are important for analytical and mechanistic studies.
Antibodies against Mazdutide support research investigating:
The Anti-Mazdutide antibody is suitable for several immunological and analytical techniques, including:
These applications allow researchers to analyze Mazdutide expression or detection in a variety of biological samples.
Mazdutide belongs to a new generation of metabolic therapeutics designed to regulate energy balance, glucose metabolism, and weight management pathways. As research into these peptide drugs expands, antibodies targeting Mazdutide are increasingly used to support experimental assays and analytical workflows.
The Anti-Mazdutide polyclonal antibody provides researchers with a reliable reagent for studying this peptide in preclinical and laboratory research settings
ProteoGenix offers competitive pricing for Anti-Mazdutide antibodies while maintaining the high quality standards required for research applications.
Our antibodies are produced under controlled conditions to ensure reliable performance, batch consistency, and cost-effective access for research laboratories working on metabolic therapeutics and peptide drug development.
ProteoGenix catalogue number ARO-A22578. For research use only.
Target: Mazdutide, IBI362, LY3305677; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Mazdutide, IBI362, LY3305677 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
